1. Home
  2. PLMR vs ABCL Comparison

PLMR vs ABCL Comparison

Compare PLMR & ABCL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Palomar Holdings Inc.

PLMR

Palomar Holdings Inc.

HOLD

Current Price

$131.33

Market Cap

3.4B

Sector

Finance

ML Signal

HOLD

Logo AbCellera Biologics Inc.

ABCL

AbCellera Biologics Inc.

HOLD

Current Price

$11.37

Market Cap

3.5B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
PLMR
ABCL
Founded
2013
2012
Country
United States
Canada
Employees
N/A
N/A
Industry
Property-Casualty Insurers
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
3.4B
3.5B
IPO Year
2019
2020

Fundamental Metrics

Financial Performance
Metric
PLMR
ABCL
Price
$131.33
$11.37
Analyst Decision
Buy
Strong Buy
Analyst Count
5
5
Target Price
$153.60
$8.40
AVG Volume (30 Days)
206.3K
9.0M
Earning Date
05-06-2026
05-11-2026
Dividend Yield
N/A
N/A
EPS Growth
60.04
10.91
EPS
3.51
N/A
Revenue
$875,967,000.00
$75,128,000.00
Revenue This Year
$192.25
N/A
Revenue Next Year
$19.34
$21.85
P/E Ratio
$36.91
N/A
Revenue Growth
58.16
160.56
52 Week Low
$100.81
$2.75
52 Week High
$147.62
$12.58

Technical Indicators

Market Signals
Indicator
PLMR
ABCL
Relative Strength Index (RSI) 50.81 65.75
Support Level $125.73 $3.38
Resistance Level $136.48 N/A
Average True Range (ATR) 3.89 0.86
MACD 0.09 0.10
Stochastic Oscillator 71.15 77.80

Price Performance

Historical Comparison
PLMR
ABCL

About PLMR Palomar Holdings Inc.

Palomar Holdings Inc that provides property and casualty insurance products to individuals and businesses. It provides insurance products serving five categories: Earthquake, Inland Marine and Other Property, Casualty, Fronting, and Crop. Company distribute products through multiple channels, including retail agents, program administrators, wholesale brokers, and partnerships with other insurance companies. The company's Earthquake product generate high premium.

About ABCL AbCellera Biologics Inc.

AbCellera Biologics Inc is a clinical-stage biotechnology company focused on discovering and developing first-in-class antibody medicines for indications with high unmet medical need. It has built a platform for advancing antibody drug programs that the company believes provides it with a competitive advantage in addressing challenging, high-value targets such as complex transmembrane proteins and novel modalities, including multispecifics and antibody-drug conjugates. Organisation's pipeline includes two drug candidates in clinical development, two development candidates in Investigational New Drug (IND/Clinical Trial Application (CTA)-enabling activities, and more than 20 active discovery programs across multiple modalities and indications.

Share on Social Networks: